Navigation Links
CriticalPoint(TM) Introduces Crosswalk Tool for Sterile Compounding Regulatory Requirements
Date:7/30/2008

CriticalPoint, LLC, in partnership with Baxa Corporation, announces the availability of a free online reference tool for understanding state laws

and regulations related to sterile compounding and USP compliance.

ENGLEWOOD, Colo., July 30 /PRNewswire/ -- Baxa Corporation announces the availability of a comprehensive new reference tool for understanding the compliance requirements for sterile compounding and USP < 797 > compliance. The interactive reference map was developed by ClinicalIQ, LLC, CriticalPoint, LLC and the National Association of Boards of Pharmacy(R). The tool offers state-specific guidelines on professional licensing and training requirements, State Board of Pharmacy harmonization with USP < 797 > guidelines and sterile compounding laws.

According to Peter Cantor, CriticalPoint development lead, "This project was developed as a response to the need among pharmacy managers and other healthcare providers to understand the legal and professional requirements for sterile compounding and licensure. As a provider of continuing education and USP < 797 > compliance training for pharmacies, we wanted to take this opportunity to give something back to the compounding community. The research provides an important tool for our customers in understanding the laws and regulations that govern their work." The complimentary reference tool is available online and is maintained by Cantor and other CriticalPoint staff members.

Baxa Corporation markets the CriticalPoint compliance training modules as part of its Productivity and Compliance Tools (PACT) product line, which includes the Skills Training, Academics and Resources (STAR) Center classroom-based training for USP < 797 > compliance and aseptic compounding. The CriticalPoint program offers an interactive, Web-based training solution for sterile compounding education and regulatory compliance. The online crosswalk tool complements the CriticalPoint training by providing up-to-date information on the training requirements in each state for professional licensure, USP < 797 > and state laws and regulations.

Notes pharmacist Phil Wettestad, Baxa Pharmacy Operations Specialist, "This crosswalk tool is a valuable resource for pharmacy managers and IV supervisors for determining their training needs and planning for regulatory compliance." Once a facility's training needs are established, the CriticalPoint - Baxa partnership provides both off-the-shelf and experiential training programs to meet them." For more information on sterile compounding compliance training programs, visit http://www.baxa.com/criticalpoint.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com.

About CriticalPoint, LLC

CriticalPoint, LLC, offers interactive Web-based training for compounding sterile preparations and services related to creating and enabling learning through technology in clinical settings. CriticalPoint e-Learning represents a best practices approach for interactive training for sterile compounding and is designed to assist healthcare providers in meeting quality assurance program goals and regulatory compliance. For more information visit http://www.criticalpoint.info.

About NABP(R)

The National Association of Boards of Pharmacy (NABP) is the independent, international, and impartial association that assists its member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health. http://www.nabp.net/

Contact:

Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR

Absolutely Public Relations: 303.984.9801 or 303.669.3558

Email: maggie@absolutelypr.com

Peter Cantor

CriticalPoint, LLC : 240-238-4352

Email: pcantor@criticalpoint.info


'/>"/>
SOURCE Baxa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
2. Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy
3. Nikon Instruments Introduces New Microscopes and Illumination Stand for Education and OEM Markets
4. Liko Introduces Two Additions to Its Stat Family of Low Friction Sheets
5. Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R)
6. Berkley Life Sciences Introduces LS Prime: A Revolutionary New Primary Liability Policy for the Life Science Industry
7. Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine
8. LI-COR(R) Biosciences Introduces New Tools for High Throughput Western Blotting
9. Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
10. Braemar Introduces the ER920W Wireless Cardiac Arrhythmia Monitor
11. LI-COR Biosciences Introduces Near-Infrared Small Animal Imager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
Breaking Biology News(10 mins):